Australia markets close in 3 hours 40 minutes

Hepion Pharmaceuticals, Inc. (HEPA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.3100-0.0600 (-4.38%)
At close: 04:00PM EDT
1.2821 -0.03 (-2.13%)
After hours: 06:05PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 7.50M
Enterprise value -5.38M
Trailing P/E 0.37
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.34
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.11

Trading information

Stock price history

Beta (5Y monthly) 1.62
52-week change 3-84.16%
S&P500 52-week change 325.59%
52-week high 320.6600
52-week low 31.2200
50-day moving average 32.1095
200-day moving average 33.7717

Share statistics

Avg vol (3-month) 371.51k
Avg vol (10-day) 329.74k
Shares outstanding 55.47M
Implied shares outstanding 65.47M
Float 84.99M
% held by insiders 10.31%
% held by institutions 113.66%
Shares short (15 Apr 2024) 463.97k
Short ratio (15 Apr 2024) 42
Short % of float (15 Apr 2024) 41.17%
Short % of shares outstanding (15 Apr 2024) 41.17%
Shares short (prior month 15 Mar 2024) 456.6k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 303 June 2019
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 311 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-72.21%
Return on equity (ttm)-171.26%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -45.19M
Net income avi to common (ttm)-48.93M
Diluted EPS (ttm)-12.3200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.79M
Total cash per share (mrq)2.7
Total debt (mrq)209.02k
Total debt/equity (mrq)2.87%
Current ratio (mrq)3.31
Book value per share (mrq)1.16

Cash flow statement

Operating cash flow (ttm)-40.89M
Levered free cash flow (ttm)-25.88M